Latest Insights - page 88 | BiopharmaTrend

[Interview] Applying AI To Shape Business Strategies At European Pharma Organizations

The application of artificial intelligence (AI) in the pharmaceutical industry has become a long-term strategic priority for most companies. However, the efficiency of this endeavor depends greatly on the availability …

Continue ›››

[Interview] Demystifying the Role of Artificial Intelligence in The Life Sciences

In this interview, Rasim Shah, Director at OKRA Technologies provided a glimpse into how the company applies state of the art machine learning technologies to solve real world challanges in …

Continue ›››

[Interview] This Vancouver-based Startup Plans To Boost Drug Design With AI

Variational AI is a newly formed artificial intelligence (AI)-driven molecule discovery & drug design startup out of Vancouver, British Columbia, Canada. The company has developed Enki, an AI-powered small molecule …

Continue ›››

Next-Generation Sequencing Is The Next Big Thing In Pharmacogenomics

Pharmacogenomics seeks to understand underlying genetic markers that influence treatment responses and modification of therapies to increase efficacy treatment success (Monte et al., 2012). This field has greatly benefited from …

Continue ›››

Hunting Dark Genes For Druggable Targets

About one in three human proteins is understudied. Even when quantifying data is available from multiple sources, "dark" genes and proteins are simply not well characterized (Figure 1). There may be …

Continue ›››

Pharma Companies Join Forces to Train AI for Drug Discovery Using Blockchain

The newly organized research project “MELLODDY” (Machine Learning Ledger Orchestration for Drug Discovery), involving ten large pharma companies and seven technology providers, is that kind of deals which can catalyze …

Continue ›››

"Hot" Research Areas in Drug Discovery - 2019

Things like gene editing, stem cells, immunotherapies and new types of biologics are now mega-trends in the pharmaceutical industry, widely covered in media, and I guess there is little doubt …

Continue ›››

New Liposome Treatment for Community-acquired Pneumonia

New research, published in The Lancet Infectious Diseases, presents the first clinical results with CAL02 in patients suffering from severe pneumonia, the first cause of infectious mortality in the world. …

Continue ›››

Artificial Intelligence For Drug Discovery Use Cases At Mind the Byte

UPDATE: Mind the Byte ceased operations and was liquidated in 2019. Artificial intelligence (AI) has become a hot topic in the biopharmaceutical environment and nearly every pharma company in the …

Continue ›››

2018: AI Is Surging In Drug Discovery Market

Updated: 10.01.2019. Newly added content is marked in the text with "Update" sign. The idea of using artificial intelligence (AI) to accelerate drug discovery process and boost a success rate …

Continue ›››

Democratizing Artificial Intelligence For Pharmaceutical Research

Over the last five years the interest of pharmaceutical professionals towards machine learning (ML) and artificial intelligence (AI) has measurably increased -- while only one “AI-related” research collaboration involving “big …

Continue ›››

Navigating In REAL Chemical Space To Find Novel Medicines (Now 3.8 Billion Molecules)

[Latest update: 27.07.2018] February 6 2018 will be marked in history as the day when an automobile embarked on a million year trip into far space. On that day, Falcon Heavy, …

Continue ›››